FDA Warning Letters The FDA issued a warning letter to an Illinois manufacturer after it isolated at least nine samples of Bacillus cereus, a bacterium that causes food poisoning, in its finished products and at least five samples taken from the manufacturing environment
As of 2023, it is the first and currently only oral GLP-1 receptor agonist available, offering an alternative to injectable formulations
While each individuals situation is unique, some on semaglutide may start seeing results in just a few weeks
Efficacy and safety of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to insulin in patients with type 1 diabetes
The study, which was part of the SELECT trial and presented at the European Society of Cardiology (ESC) Conference in 2024, initially focused on the cardiovascular benefits of Wegovy